In this study we have cloned AGAP2 isoform 2 proximal promoter from genomic DNA, and studied the regions that were contributing to AGAP2 expression using prostate cancer cell lines and chronic myeloid leukaemia (CML) cell lines as models. Here, AGAP2 is linked to prostate cancer.